Mankind, other pharma stocks rally up to 7%; Nifty Pharma scales fresh peak. What lies ahead?Pharma stocks surged on Wednesday, supported by strong earnings and a weakening rupee, even as Sensex and Nifty traded lower. The Nifty Pha...
20 May, 2026, 12.05 PM IST
Laurus Labs adds Rs 40,150 crore to investors' wealth in a year with 120% rally. Buy, hold or book profits?Laurus Labs has significantly boosted investor wealth, adding over Rs 40,000 crore in a year with a 120% stock rally. Driven by business im...
19 May, 2026, 10.34 AM IST
Ajanta Pharma buyback: Last day today to buy shares for Rs 285 crore special situation opportunityAjanta Pharma has set May 30 as the record date for its Rs 285 crore share buyback,. The buyback, at a premium of 12.6%, targets 10,28,881 ...
29 May, 2024, 12.48 PM IST
Ajanta Pharma shares jump over 13% on strong Q4 results, buyback plansAjanta Pharma shares jumped 13% to Rs 2,532 in Friday's trade on BSE after the firm's consolidated net profit increased 66% year-on-year (Y...
03 May, 2024, 12.06 PM IST
Ajanta Pharma Q4 Results: Net profit soars 66% YoY to Rs 203 crRevenue from operations rose to Rs 1,054 crore in the fourth quarter of FY24 as compared with Rs 882 crore in the year-ago period, Ajanta P...
02 May, 2024, 10.32 PM IST
This smallcap pharma company declares 350% interim dividend; record date fixedPayment of interim dividend of Rs 7/- (350%) per equity share on the face-value of Rs 2/- per share for the Financial Year 2022-23,” said t...
03 Nov, 2022, 09.05 PM IST
Ajanta Pharma Q4 Results: Net profit falls 5% to Rs 151 crFor the year ended March 31, 2022, the company posted a PAT of Rs 713 crore. It was Rs 654 crore in FY21. Revenue from operations rose to R...
10 May, 2022, 08.10 PM IST
Ajanta Pharma Q3 Results: Net profit up 9% at Rs 192 croreDuring the period under review, the drug maker reported sales of Rs 256 crore in the domestic market, compared to Rs 220 crore earlier.
31 Jan, 2022, 05.49 PM IST
Ajanta Pharma Q2 results: Profit up 15% at Rs 196 croreRevenue from operations rose to Rs 885 crore in the second quarter as compared with Rs 716 crore in the year-ago period, Ajanta Pharma said...
29 Oct, 2021, 05.50 PM IST
Ajanta Pharma Q3 results: Net profit rises 64% to Rs 177 crThe company had posted a net profit of Rs 108 crore for the corresponding period of the previous fiscal, Ajanta Pharma said in a BSE filing.
02 Feb, 2021, 10.16 PM IST
Ajanta Pharma Q1 results: Profit up 29% at Rs 148 croreAjanta Pharma on Thursday reported 28.90 per cent rise in consolidated net profit to Rs 147.76 crore for the quarter ended June 30, 2020.
30 Jul, 2020, 04.16 PM IST
Buy Ajanta Pharma, target price Rs 1,880: EdelweissThe brokerage estimates earnings to expand at a 19% CAGR over FY20–22, led by 11% top-line CAGR and 250 bps margin expansion.
22 May, 2020, 11.49 AM IST
Ajanta Pharma Q3 profit dips 55% to Rs 67 croreConsolidated revenue from operations of the company stood at Rs 485.11 crore for the quarter.
30 Jan, 2019, 10.02 PM IST
HC allows Indian firm to export drug in which Bayer has patentBayer admitted before the court that it has not used its patents for commercial exploitation in India while Ajanta had launched its drug ba...
29 Jan, 2017, 12.46 PM IST
Ajanta Pharma slips over 14% on USFDA import alertAjanta Pharma was trading 4.35 per cent lower at Rs 1,706 in early trade around 10.30 am (IST) on BSE.
24 Jan, 2017, 11.32 AM IST
Ajanta Pharma Q1 net up 80 per cent at Rs 58.72 croreShares of Ajanta Pharma were trading at Rs 1,590.75 per scrip in the afternoon trade on BSE, down 8.60% from the previous close.
05 Aug, 2014, 04.49 PM IST
- Ajanta Pharma rallies 20% post Q3 results
The company posted a net profit of Rs 32.6 crore for the quarter, up 76 per cent, compared to a net profit of Rs 18.5 crore in the same per...
23 Jan, 2013, 03.10 PM IST